


SmartPharm Therapeutics Revenue
Biotechnology Research • Cambridge, Massachusetts, United States • 1-10 Employees
SmartPharm Therapeutics revenue & valuation
| Annual revenue | $1,700,000 |
| Revenue per employee | $850,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,500,000 |
| Total funding | $10,500,000 |
Key Contact at SmartPharm Therapeutics
David Knowlton
Associate Director of Research and Development
Company overview
| Headquarters | Cambridge, Massachusetts, United States |
| Phone number | +18573278740 |
| Website | |
| SIC | 283 |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
About SmartPharm Therapeutics
SmartPharm Therapeutics, now a subsidiary of Sorrento Therapeutics, is a gene therapy company applying the next generation of non-viral DNA and RNA technologies to treat serious human diseases. Founded with the vision of producing “Biologics from Within,” SmartPharm is focused on bringing together unique technology and developmental capabilities for the treatment of rare diseases including lysosomal storage disorders. SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company that has benefited from the first decades of learning in gene therapy development to produce an evolved therapeutic platform. We integrate these insights with key technologies and engineering capabilities to enable us to produce optimal gene-encoded therapeutics for patients.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
SmartPharm Therapeutics Tech Stack
Discover the technologies and tools that power SmartPharm Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Security
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Programming languages
Frequently asked questions
4.8
40,000 users



